The Federal Health Administration has approved a permanent implant for the first time to treat men’s urinary symptoms caused by an enlarged prostate. The FDA approved the Urolift system to improve urine flow for men 50 and older who suffer from prostate-induced urinary problems. The device improves flow by holding back prostate that pushes against… Continue Reading »

Amgen Announces Positive Top-Line Results From Phase 3 MENDEL-2 Trial Of Evolocumab (AMG 145) In Patients With High Cholesterol Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Dec. 17, 2013 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the Phase 3 MENDEL-2 (Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2) trial… Continue Reading »

Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain Following major orthopedic surgery, Sufentanil NanoTab- treated patients experienced significantly greater reduction in pain as measured by SPID-48 vs. placebo (p<0.001) Results confirm all previously reported Phase 3 trial outcomes, supporting submission of… Continue Reading »